T-E Pharma Web Team – Page 4 – T-E Pharma Holding Company

The 2024 Tang Prize is awarded to three scientists for the development of GLP-1

June 24, 2024

The 2024 Tang Prize in Biopharmaceutical Science has cast a spotlight on GLP-1 receptor agonists, sparking a global race among […]

March 14, 2024

Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform! We are thrilled

March 5, 2024

Dr. Kun-Po Li, BD Director of T-E Meds, an is set to captivate the audience at The BiG ADC/XDC Conference

February 26, 2024

We’re thrilled to announce that Dr. Hsing-Mao Chu, CEO of T-E Meds is honored to present at The 5th ADC

February 20, 2024

Our Chairman, Dr. Tse-Wen Chang and VP of R&D, Dr. Hsing-Mao Chu are honored speakers at the prestigious J.P. Morgan

February 17, 2024

Congratulations to our founder, Dr. Tse-Wen Chang, the inventor of Xolair.We are thrilled to learn that Xolair’s potential benefits are extending

January 15, 2024

Website link: https://news.gbimonthly.com/tw/article/show.php?num=64320

January 12, 2024

The founder of Immunwork and T-E Meds, Dr. Tse-Wen Chang, shared the latest developments of the two companies on 11th

October 11, 2023

Dr. Hsing-Mao Chu, CEO at T-E Meds, will be presenting at the prestigious World ADC conference in San Diego on October

September 25, 2023

Reported link: https://www.ctee.com.tw/news/20230925700053-439901